1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of first-line arsenic trioxide and retinoic acid treatment on outcome in therapy-related acute promyelocytic leukemia patients
    Meeting Abstract

    Kayser, S.; Krzykalla, J.; Norsworthy, K.; Elliott, M.; Grimwade, D.; Hills, R. K.; Gonzales, P.; Racil, Z.; Mayer, J.; Baer, M. R.; more...
    Annals of Hematology (2017)

    Fulltext@MSK | Save
  • Targeting IDH mutations in acute myeloid leukemia
    Meeting Abstract

    Tallman, M. S.; Stein, E. M.; Coombs, C. C.; Levine, R. L.
    Annals of Hematology (2017)

    Fulltext@MSK | Save
  • Organ biomarker responses in patients with light chain amyloidosis treated with NEOD001 are independent of previous hematologic response
    Meeting Abstract

    Gertz, M. A.; Comenzo, R. L.; Landau, H.; Sanchorawala, V.; Weiss, B. M.; Zonder, J. A.; Walling, J.; Kinney, G. G.; Koller, M.; Schenk, D. B.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Re-immunization following autologous hematopoietic stem cell transplantation (Auto HCT) is safe and effective in patients with multiple myeloma receiving lenalidomide maintenance
    Meeting Abstract

    Shah, G.; Palazzo, M.; Copelan, O.; Seier, K.; Devlin, S.; Hassoun, H.; Korde, N.; Lendvai, N.; Lesokhin, A.; Mailankody, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Improvement of response for multiple myeloma patients on lenalidomide maintenance after autologous hematopoietic stem cell transplantation (Auto HCT)
    Meeting Abstract

    Shah, G.; Assal, A.; Hsu, M.; Devlin, S.; Hassoun, H.; Korde, N.; Lendvai, N.; Lesokhin, A.; Mailankody, S.; Smith, E.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • NEOD001 demonstrates organ biomarker responses in patients with light chain amyloidosis and persistent organ dysfunction: Results from a phase 1/2 study
    Meeting Abstract

    Gertz, M. A.; Comenzo, R. L.; Landau, H.; Sanchorawala, V.; Weiss, B. M.; Zonder, J. A.; Walling, J.; Kinney, G. G.; Koller, M.; Schenk, D. B.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Post autologous transplant (autoHCT)therapies in high risk MM. Subgroup analysis of Phase III BMTCTN 0702 STAMINA: autoHCT followed by lenalidomide maintenance(Len)(AM) vs auto HCT and Len and bortezomib (BZ) and dexamethasone consolidation Len maintenance(ACM) vs tandem autoHCT Len maintenance
    Meeting Abstract

    Krishnan, A.; Pasquini, M.; Blackwell, B.; Knust, K.; Bashey, A.; Devine, S.; Efebera, Y.; Ganguly, S.; Gasparetto, C.; Geller, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Panobinostat acts synergistically with ibrutinib in diffuse large B cell lymphoma cells with MyD88 L265 mutations
    Journal Article

    Mondello, P.; Brea, E. J.; De Stanchina, E.; Toska, E.; Chang, A. Y.; Fennell, M.; Seshan, V.; Garippa, R.; Scheinberg, D. A.; Baselga, J.; more...
    JCI Insight (2017)

    Fulltext@MSK | Save
  • Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: An analysis of patients included in the CORAL study
    Journal Article

    Van den Neste, E.; Schmitz, N.; Mounier, N.; Gill, D.; Linch, D.; Trneny, M.; Bouadballah, R.; Radford, J.; Bargetzi, M.; Ribrag, V.; more...
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation for MDS and CMML: Recommendations from an international expert panel
    Journal Article

    de Witte, T.; Bowen, D.; Robin, M.; Malcovati, L.; Niederwieser, D.; Yakoub-Agha, I.; Mufti, G. J.; Fenaux, P.; Sanz, G.; Martino, R.; more...
    Blood (2017)

    Fulltext@MSK | Save